Mantej Chhina

[Mantej Chhina @Nimi_Chhina]

I am excited to share that I’ll chair panel on "Accelerated Approval: Catalyzing Advancements in the Cell and Gene Therapy Field" on Oct 11, 2023 at @alliancerm’s #CGMesa23.

Be sure to mark it on your agenda and don’t miss out! https://t.co/K0CdN5MoFF

[FDLI @foodanddruglaw]

Let the fun begin on Day 2 of the FDLI Annual! We are all set to kick-off with @RegulatoryAtty @Nimi_Chhina
#fdli_TAKEOVER
#FDLIAnnual23

[FDLI @foodanddruglaw]

When you do a Twitter takeover, you have to take a giant selfie, right? We’re underway at #FDLIAnnual23!

Looking forward to great speakers and panels today. Let us know what you’re most excited for.

#FDLI_TAKEOVER

[FDLI @foodanddruglaw]

Wonderful remarks from @US_FDA Chief Counsel Mark Raza, with insightful and entertaining reflections from his 30+ year career with the Office of Chief Counsel. Thanks so much for joining us this morning.

#FDLIAnnual23 #FDLI_TAKEOVER

[Dr. Robert M. Califf @DrCaliff_FDA]

I was pleased to speak at the @foodanddruglaw annual conference. Few groups can match the level of understanding of the work of the FDA as FDLI. This understanding is particularly important these days, as the FDA faces significant challenges that go to the heart of what we do.

[FDLI @foodanddruglaw]

A very timely discussion on recent Congressional actions and their impact on FDA, industry, and public health. Great takeaways, predictions, and hot takes.

#FDLIAnnual23 #FDLI_TAKEOVER

[FDLI @foodanddruglaw]

The day is finally here! So excited to kick off #FDLIAnnual23! Your conference co-chairs @RegulatoryAtty and @Nimi_Chhina, and the illustrious Laura Brown, are here and excited to see you! Be sure to follow along as we cover highlights here today & tomorrow.

#FDLI_TAKEOVER

[ASGCT @ASGCTherapy]

Timely analysis by @DrDDrago, Adora Ndu (@BridgeBioPharma), & @Nimi_Chhina looking back 5 years since #RMAT in Planning for progress: A US regulatory approach to advancing the clinical development of #genetherapies. #PDUFA #ASGCTadvocacy https://t.co/9nMmJGPRtX

[Molecular Therapy Family of Journals @MolTherapy]

.@Nimi_Chhina, @DrDDrago, & Adora Ndu wrote in @moltherapy about progress made under the #RMAT designation program, barriers to efficient clinical development of #genetherapy products, and the role of PDUFA VII. Read it here: https://t.co/EQ9WcM7gcS